Mazzariello Gina 4
4 · Amylyx Pharmaceuticals, Inc. · Filed Oct 2, 2024
Insider Transaction Report
Form 4
Mazzariello Gina
Chief Legal Officer
Transactions
- Sale
Common Stock
2024-09-30$3.20/sh−8,709$27,840→ 142,768 total
Footnotes (2)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.12 to $3.235. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.